FATE News and Press, Fate Therapeutics Inc. From 09/12/21

This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion in Assets Under Management. After the Q2-2021 13F filings the consensus holdings were updated, 6 stocks were removed and 6 added from the un...

Cathie Wood has won investors’ confidence with her funds’ significant gains last year. The renowned investor believes that investing in innovation is the key to success. And Wall Street analysts are bullish on Zillow (Z) and Fate Therapeutics (FATE), which are held in Woodȁ...

This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. After the Q2-2021 13F filings, the consensus holdings were updated, 6 stocks were removed and 6 added from the univ...

Using the quarterly 13F filings, we extract 50 consensus stocks from 40 large hedge funds, each fund with more than $3.5 billion Assets Under Management. After the Q1-2021 13F filings, the consensus holdings are updated, 5 stocks were removed and 6 added from the universe now holds 48...

Tesla (NASDAQ:TSLA) stirred fresh interest in the electric-vehicle sector on Friday following its well-publicized AI event the day before. However, the sector's Friday rally was really led by gains in Lordstown (NASDAQ:RIDE), which displayed its product at a separate showcase. The space as a ...

Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (NASDAQ:ONVO) +16%. Creatd (NASDAQ:CRTD...

Shares of Fate Therapeutics (NASDAQ: FATE) , a clinical-stage biotechnology company, are sliding in response to interim data from ongoing clinical trials with two of its new drug candidates. Investors unimpressed with the company's new approach to cancer drug development shaved 17.9...

Gainers: GeoVax Labs (NASDAQ:GOVX) +52%, Flora Growth (NASDAQ:FLGC) +30%, XTL Biopharmaceuticals (NASDAQ:XTLB) +17%, Organovo (NASDAQ:ONVO) +16%, Impel NeuroPharma (NASDAQ:IMPL) +11%. Losers: Progenity (NASDAQ:PROG) -55%, Sonnet BioTherapeutics (NA...

10 of 14 Patients in FT596 Single-Dose Escalation Cohorts 2 and 3 Achieved Objective Response; 7 Patients Achieved Complete Response, including 2 of 3 Patients Treated with FT596 in Combination with Rituximab Following Autologous CD19 CAR T-cell Therapy 8 of 11 Patients in FT516...

Using the quarterly 13F filings we extract 50 consensus stocks from 40 large hedge funds, each fund with more than $3.5 billion Assets Under Management. After the Q1-2021 13F filings the consensus holdings are updated, 5 stocks were removed and 6 added from the universe now holds 48 s...